The association of coffee intake with liver cancer incidence and chronic liver disease mortality in male smokers
暂无分享,去创建一个
R. Sinha | D. Albanes | J. Virtamo | S. Weinstein | N. Freedman | P. Taylor | K. McGlynn | G. Lai | Neal D. Freedman | Rashmi Sinha | P. R. Taylor
[1] Carlo La Vecchia,et al. Hepatocellular carcinoma epidemiology. , 2014, Best practice & research. Clinical gastroenterology.
[2] Lei Dong,et al. Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway. , 2013, Toxicology.
[3] Sun-Mee Lee,et al. Protective effects of chlorogenic acid against ischemia/reperfusion injury in rat liver: molecular evidence of its antioxidant and anti-inflammatory properties. , 2012, The Journal of nutritional biochemistry.
[4] J. Samet,et al. Total cholesterol and cancer risk in a large prospective study in Korea. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] Z. Bao,et al. Coffee consumption and risk of cancers: a meta-analysis of cohort studies , 2011, BMC Cancer.
[6] Jian-Min Yuan,et al. Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study , 2011, Cancer Causes & Control.
[7] Mitsuru Sugawara,et al. In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid. , 2011, International journal of pharmaceutics.
[8] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[9] R. Bataller,et al. Cigarette smoking and chronic liver diseases , 2010, Gut.
[10] P. Muriel,et al. Coffee and liver diseases. , 2010, Fitoterapia.
[11] J. Hoofnagle,et al. Increased caffeine consumption is associated with reduced hepatic fibrosis , 2010, Hepatology.
[12] M. Woodward,et al. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. , 2009, Archives of internal medicine.
[13] C. la Vecchia,et al. Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. , 2009, Cancer letters.
[14] R. Hayes,et al. Prediagnostic Total and High-Density Lipoprotein Cholesterol and Risk of Cancer , 2009, Cancer Epidemiology, Biomarkers & Prevention.
[15] William M. Lee,et al. Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C , 2009, Hepatology.
[16] C. Bosetti,et al. Coffee drinking and hepatocellular carcinoma: An update , 2009, Hepatology.
[17] G. Farrell,et al. Prevention of hepatocellular carcinoma in nonviral‐related liver diseases , 2009, Journal of gastroenterology and hepatology.
[18] J. Shearer,et al. Coffee, glucose homeostasis, and insulin resistance: physiological mechanisms and mediators. , 2008, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.
[19] E. Vartiainen,et al. Joint effects of coffee consumption and serum gamma‐glutamyltransferase on the risk of liver cancer , 2008, Hepatology.
[20] C. la Vecchia,et al. Coffee drinking and hepatocellular carcinoma risk: A meta‐analysis , 2007, Hepatology.
[21] H. El‐Serag,et al. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.
[22] S. Larsson,et al. Coffee consumption and risk of liver cancer: a meta-analysis. , 2007, Gastroenterology.
[23] Antonella Afeltra,et al. Diabetes in chronic liver disease: from old concepts to new evidence , 2006, Diabetes/metabolism research and reviews.
[24] G. Friedman,et al. Coffee, cirrhosis, and transaminase enzymes. , 2006, Archives of internal medicine.
[25] H. El‐Serag,et al. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[26] D. Grobbee,et al. Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials , 2005, Journal of hypertension.
[27] H. Glatt,et al. Coffee diterpenes prevent the genotoxic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and N-nitrosodimethylamine in a human derived liver cell line (HepG2). , 2005, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[28] S. Kono,et al. Coffee consumption and glucose tolerance status in middle-aged Japanese men , 2004, Diabetologia.
[29] L. Bouter,et al. Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study , 2004, Diabetologia.
[30] K. Mochida,et al. In vitro antioxidative effects and tyrosinase inhibitory activities of seven hydroxycinnamoyl derivatives in green coffee beans. , 2004, Journal of agricultural and food chemistry.
[31] A. Ahlbom,et al. Coffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women , 2004, Journal of internal medicine.
[32] Frank Hu,et al. Coffee Consumption and Risk for Type 2 Diabetes Mellitus , 2004, Annals of Internal Medicine.
[33] A. Tverdal,et al. Coffee intake and mortality from liver cirrhosis. , 2003, Annals of epidemiology.
[34] A. Constable,et al. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[35] R. Schulte‐Hermann,et al. Enhancement of the chemoprotective enzymes glucuronosyl transferase and glutathione transferase in specific organs of the rat by the coffee components kahweol and cafestol , 2002, Archives of Toxicology.
[36] D. Albanes,et al. The Finnish Cancer Registry as Follow-Up Source of a Large Trial Cohort , 2002, Acta oncologica.
[37] J. Fraumeni,et al. International trends and patterns of primary liver cancer , 2001, International journal of cancer.
[38] P. Whelton,et al. Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. , 2001, American journal of epidemiology.
[39] A. Constable,et al. The coffee-specific diterpenes cafestol and kahweol protect against aflatoxin B1-induced genotoxicity through a dual mechanism. , 1998, Carcinogenesis.
[40] K. Tanaka,et al. Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers. , 1998, International journal of epidemiology.
[41] G. Steil,et al. Physiological insulinemia acutely modulates plasma leptin. , 1998, Diabetes.
[42] E. Vartiainen,et al. Determinants of gamma-glutamyltransferase: positive interaction with alcohol and body mass index, negative association with coffee. , 1997, American journal of epidemiology.
[43] A. Huggett,et al. Analysis of the content of the diterpenes cafestol and kahweol in coffee brews. , 1997, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[44] L. Barbara,et al. Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. , 1997, Archives of internal medicine.
[45] M. Katan,et al. Levels of the cholesterol-elevating diterpenes cafestol and kahweol in various coffee brews , 1995 .
[46] S. Kono,et al. Coffee and serum gamma-glutamyltransferase: a study of self-defense officials in Japan. , 1994, American journal of epidemiology.
[47] W. Ratnayake,et al. Lipid content and composition of coffee brews prepared by different methods. , 1993, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[48] J. Palmgren,et al. Reproducibility and validity of dietary assessment instruments. I. A self-administered food use questionnaire with a portion size picture booklet. , 1988, American journal of epidemiology.
[49] E. Arnesen,et al. The Tromsø Heart Study: distribution of, and determinants for, gamma-glutamyltransferase in a free-living population. , 1986, Scandinavian journal of clinical and laboratory investigation.
[50] Coffee Drinking , 1891, Hall's journal of health.
[51] M. F. M. Diniz,et al. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease. , 2012, Arquivos de gastroenterologia.
[52] J. Samet,et al. Total cholesterol and cancer risk in a large prospective study in Korea , 2010 .
[53] J. Everhart,et al. Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. , 2005, Gastroenterology.
[54] Bob Martens,et al. Analysis of Content , 2002 .
[55] R. Schulte‐Hermann,et al. The coffee components kahweol and cafestol induce γ-glutamylcysteine synthetase, the rate limiting enzyme of chemoprotective glutathione synthesis, in several organs of the rat , 2001, Archives of Toxicology.
[56] K. Suzuki,et al. Effects of coffee consumption against the development of liver dysfunction: a 4-year follow-up study of middle-aged Japanese male office workers. , 2000, Industrial health.
[57] The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. , 1994, Annals of epidemiology.
[58] J. Fraumeni,et al. Design, Methods, Participant Characteristics, and Compliance , 1993 .